Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enantiospecific Allosteric Modulation of Cannabinoid 1 Receptor
Robert B. Laprairie, Pushkar M. Kulkarni, Jeffrey R. Deschamps, et al.
ACS Chemical Neuroscience (2017) Vol. 8, Iss. 6, pp. 1188-1203
Closed Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

The cannabinoid system and pain
Stephen G. Woodhams, Victoria Chapman, David P. Finn, et al.
Neuropharmacology (2017) Vol. 124, pp. 105-120
Open Access | Times Cited: 239
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
Dongchen An, Steve Peigneur, Louise Antonia Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5064-5064
Open Access | Times Cited: 159
In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa
Ayat Zagzoog, Kawthar A. Mohamed, Hye Ji J. Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 144
The Magic Methyl and Its Tricks in Drug Discovery and Development
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Carlos Alberto Manssour Fraga
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1157-1157
Open Access | Times Cited: 42
Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery
Paolo Conflitti, Edward Lyman, Mark S.P. Sansom, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 2
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 88-127
Open Access | Times Cited: 132
Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence
Richard A. Slivicki, Zhili Xu, Pushkar M. Kulkarni, et al.
Biological Psychiatry (2017) Vol. 84, Iss. 10, pp. 722-733
Open Access | Times Cited: 119
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
CB1 Cannabinoid Receptor Signaling and Biased Signaling
Luciana M. Leo, Mary E. Abood
Molecules (2021) Vol. 26, Iss. 17, pp. 5413-5413
Open Access | Times Cited: 74
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities
Leepakshi Khurana, Ken Mackie, Daniele Piomelli, et al.
Neuropharmacology (2017) Vol. 124, pp. 3-12
Open Access | Times Cited: 72
The Trifluoromethyl Group as a Bioisosteric Replacement of the Aliphatic Nitro Group in CB1 Receptor Positive Allosteric Modulators
Chih‐Chung Tseng, Gemma L. Baillie, Giulia Donvito, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 10, pp. 5049-5062
Open Access | Times Cited: 64
Positive Allosteric Modulation of CB1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward
Richard A. Slivicki, Vishakh Iyer, Sonali S. Mali, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 57
Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer’s Disease
Hina Kanwal, Moris Sangineto, Martina Ciarnelli, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4050-4050
Open Access | Times Cited: 6
Application of Fluorine- and Nitrogen-Walk Approaches: Defining the Structural and Functional Diversity of 2-Phenylindole Class of Cannabinoid 1 Receptor Positive Allosteric Modulators
Sumanta Garai, Pushkar M. Kulkarni, Peter C. Schaffer, et al.
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 2, pp. 542-568
Open Access | Times Cited: 53
Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor
Noureldin Saleh, Oliver Hucke, Gert Kramer, et al.
Angewandte Chemie International Edition (2018) Vol. 57, Iss. 10, pp. 2580-2585
Closed Access | Times Cited: 49
Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model
Robert B. Laprairie, Amina M. Bagher, Jillian L. Rourke, et al.
Neuropharmacology (2019) Vol. 151, pp. 1-12
Open Access | Times Cited: 47
Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
Dinesh Thapa, Elizabeth A. Cairns, Anna-Maria Szczesniak, et al.
Molecules (2020) Vol. 25, Iss. 2, pp. 417-417
Open Access | Times Cited: 40
Selective Photoswitchable Allosteric Agonist of a G Protein-Coupled Receptor
Prashant Donthamsetti, David B. Konrad, Belinda E. Hetzler, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 24, pp. 8951-8956
Open Access | Times Cited: 37
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1
Siyuan Shen, Chao Wu, Guifeng Lin, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 24
Open Access | Times Cited: 5
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
Dai Lu, Sri Sujana Immadi, Zhixing Wu, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 324-335
Open Access | Times Cited: 39
Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias
Jamie J. Manning, Hayley M. Green, Michelle Glass, et al.
Neuropharmacology (2021) Vol. 193, pp. 108611-108611
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top